review Open AccessTop 1% cited
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Annals of the Rheumatic Diseases · 2017 · Vol. 76(6) · pp. 960–977
Josef S Smolen✉(Klinik Hietzing)Robert Landewé(Zuyderland Medisch Centrum)Johannes Bijlsma(University Medical Center Utrecht)Gerd Burmester(Humboldt-Universität zu Berlin)Katerina Chatzidionysiou(Karolinska Institutet)Maxime Dougados(Hôpital Cochin)J. Nam(University of Leeds)Sofía Ramiro(Leiden University Medical Center)Marieke Voshaar(University of Twente)Ronald van Vollenhoven(Zuyderland Medisch Centrum)Daniel Aletaha(Medical University of Vienna)Martin Aringer(Klinik und Poliklinik für Psychotherapie und Psychosomatik)Maarten Boers(Amsterdam UMC Location Vrije Universiteit Amsterdam)Christopher D. Buckley(Queen Elizabeth Hospital Birmingham)Frank Buttgereit(Humboldt-Universität zu Berlin)Vivian P. Bykerk(Hospital for Special Surgery)Myrna CardielBernard Combe(Université de Montpellier)Maurizio Cutolo(University of Genoa)Yvonne van Eijk‐Hustings(Maastricht University)Paul Emery(Leiden University Medical Center)Axel Finckh(University Hospital of Geneva)Cem Gabay(University Hospital of Geneva)Juan J. Gómez‐Reino(Fundación Ramón Domínguez)Laure Gossec(Sorbonne Université)J.-E. Gottenberg(Centre National de la Recherche Scientifique)Johanna M W Hazes(Erasmus MC)T. Huizinga(University of Twente)Meghna Jani(University of Manchester)Д. Е. Каратеев(Association of Rheumatologists of Russia)Marios Kouloumas(European League Against Rheumatism)Tore Kvien(Diakonhjemmet Hospital)Zhanguo Li(Peking University)Xavier Mariette(Université Paris-Sud)Iain B. McInnes(University of Glasgow)Eduardo MyslerPeter Nash(The University of Queensland)Karel Pavelká(Charles University)Gyula Poór(Semmelweis University)Christophe Richez(Centre National de la Recherche Scientifique)Piet L. C. M. van Riel(Ziekenhuis Bernhoven)Andrea Rubbert‐Roth(University of Cologne)Kenneth G. Saag(University of Alabama at Birmingham)José António Pereira da Silva(Hospitais da Universidade de Coimbra)Tanja Stamm(Statistics Austria)Tsutomu Takeuchi(Keio University Hospital)René Westhovens(KU Leuven)Maarten de Wit(Amsterdam UMC Location Vrije Universiteit Amsterdam)Désirée van der Heijde(Leiden University Medical Center)
Rheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical MethodsAutoimmune and Inflammatory Disorders ResearchMedicineAbataceptAdalimumabCertolizumab pegolTocilizumabInfliximabGolimumabEtanerceptRituximabRheumatoid arthritis
MeSH terms
Antibodies, MonoclonalArthritis, RheumatoidDrug Therapy, CombinationGlucocorticoidsHumansMethotrexatePatient ParticipationTime FactorsTumor Necrosis Factor-alphaAntirheumatic AgentsProtein Kinase InhibitorsJanus KinasesDrug Substitution
Funding
- European League Against Rheumatism
Citations
5,757
FWCI
536.45
field-weighted impact
References
383
Percentile
100%
vs. same field & year
Citations per year
Cited by
Management of Rheumatoid Arthritis: An Overview
Cells · 2021 · 961 citations
A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers
BMJ Open · 2013 · 382 citations
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
European Journal of Medicinal Chemistry · 2018 · 541 citations
Tocilizumab: A Review in Rheumatoid Arthritis
Drugs · 2017 · 403 citations
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Frontiers in Immunology · 2020 · 1,136 citations
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
Annals of the Rheumatic Diseases · 2019 · 779 citations
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Annals of the Rheumatic Diseases · 2015 · 1,431 citations
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Annals of the Rheumatic Diseases · 2017 · 1,541 citations
References
PRIMER ON THE RHEUMATIC DISEASES
Journal of the American Medical Association · 1959 · 807 citations
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
Arthritis & Rheumatism · 2005 · 1,780 citations
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
Arthritis & Rheumatism · 1998 · 1,638 citations
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
Arthritis & Rheumatism · 2004 · 1,165 citations
Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks
Arthritis & Rheumatism · 2006 · 1,631 citations
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial
Arthritis & Rheumatism · 2004 · 1,168 citations
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial
Arthritis & Rheumatism · 2006 · 1,050 citations
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
Annals of the Rheumatic Diseases · 2009 · 804 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.